Get the Stockscreener App
4.59
7.75%
0.33
Pre-market:
4.41
-0.18
-3.92%
Advanced Biomed Inc stock is traded at $4.59, with a volume of 6.28M.
It is up +7.75% in the last 24 hours and down -13.27% over the past month.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
See More
Previous Close:
$4.26
Open:
$5.37
24h Volume:
6.28M
Relative Volume:
44.31
Market Cap:
$6.26M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+16.50%
1M Performance:
-13.27%
6M Performance:
-46.62%
1Y Performance:
+0.00%
1-Day Range:
$3.90
$5.82
1-Week Range:
$3.86
$5.82
52-Week Range:
$3.61
$80.00
Advanced Biomed Inc Stock (ADVB) Company Profile
Name
Advanced Biomed Inc
Sector
Industry
Phone
86-21-20510823
Address
401 RYLAND ST, RENO
Compare ADVB vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADVB
Advanced Biomed Inc
|
4.59 | 5.81M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Advanced Biomed Inc Stock (ADVB) Latest News
Surge for ADVB: New Partnerships and Market Strategies Drive Momentum - timothysykes.com
Advanced Biomed Executes Reverse Split to Maintain Nasdaq Listing - TipRanks
Advanced Biomed (NASDAQ: ADVB) completes 1-for-20 reverse stock split - Stock Titan
Volume Report: Is Columbus Acquisition Corp Debt Equity Composite Units stock a good pick for beginnersNew Guidance & Fast Moving Stock Watchlists - baoquankhu1.vn
Sentiment Review: Does GROY have strong fundamentalsPortfolio Update Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Moving Averages: Is Advanced Biomed Inc currently under institutional pressureJuly 2025 Drop Watch & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
How Advanced Biomed Inc. stock performs during Fed tightening cyclesWeekly Trading Summary & Expert Approved Trade Ideas - mfd.ru
Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance By Investing.com - Investing.com South Africa
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation - 富途牛牛
Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance - Investing.com Canada
Uber to invest over $100 million in autonomous vehicle charging amid robotaxi push - Bitget
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer - Bitget
Advanced Biomed Inc. Announces 1-for-20 Reverse Stock Split Effective February 20, 2026 - Quiver Quantitative
Advanced Biomed Inc. announces 1 for 20 share consolidation - marketscreener.com
Advanced Biomed Inc. Announces 1 For 20 Share Consolidation - TradingView
Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 - The Manila Times
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Will Advanced Biomed Inc. stock deliver better than expected guidanceJuly 2025 Trade Ideas & Safe Swing Trade Setups - mfd.ru
Advanced Biomed Inc. SEC 10-Q Report - TradingView
Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusCIntegrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - Bitget
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - The Manila Times
Nasus Pharma Announces Closing of $15.0 Million Private Placement - Bitget
Advanced Biomed Inc. Announces 120‑Case Feasibility Study - GlobeNewswire
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - Sahm
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
IPO window reopens, med-tech class of 2025 gains 26% - BioWorld MedTech
Guidance Update: Does Prelude Therapeutics Incorporated have a sustainable dividend2025 Trading Recap & Smart Investment Allocation Insights - baoquankhu1.vn
Can Advanced Biomed Inc. outperform under higher oil pricesWeekly Investment Recap & Technical Pattern Based Buy Signals - mfd.ru
Is Advanced Biomed Inc. a strong candidate for buy and holdJuly 2025 Fed Impact & Free Reliable Trade Execution Plans - mfd.ru
Trading Action: Whats the fair value of Advanced Biomed Inc stock2025 Buyback Activity & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Advanced Biomed Completes Private Placement Equity Financing - TipRanks
Advanced Biomed Signs Securities Purchase Agreement With Certain Investors - TradingView
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aug Outlook: Can CCRN scale operations efficientlyJuly 2025 Outlook & Capital Efficiency Focused Strategies - baoquankhu1.vn
Advanced Biomed Inc. amends spin-off agreement, sets repayment terms for subsidiary - Investing.com India
Advanced Biomed (ADVB) Stock Trends and Sentiment 2026 - MarketBeat
Advanced Biomed Secures Repayment Terms in Hong Kong Spin-Off - TipRanks
Advanced Biomed Signs Supplemental Agreement With Wei Ha Hui - TradingView
Aug Patterns: Whats HTGCs historical return2025 Investor Takeaways & Low Risk Growth Stock Ideas - baoquankhu1.vn
FOMO Trade: What is EICBs 5 year growth outlookPortfolio Value Summary & Weekly High Conviction Ideas - baoquankhu1.vn
Big Money Moves: Is MicroSectors Travel 3X Leveraged ETNs due May 29 2042 showing insider buyingWeekly Trading Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Gap Down: Is Seanergy Maritime Holdings Corp showing insider buying2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Aug Catalysts: What hedge funds are buying AVALEarnings Miss & Safe Capital Growth Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Advanced Biomed Inc. Delays Quarterly Report Filing - MSN
Advanced Biomed Appeals Nasdaq Delisting, Plans Reverse Split - TipRanks
Advanced Biomed Received Notice of Delisting - TradingView
Trading Recap: Is PPTA benefiting from innovation trendsWeekly Market Outlook & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Can Advanced Biomed Inc. maintain sales growthTrade Signal Summary & Real-Time Market Sentiment Reports - bollywoodhelpline.com
Day Trade: What are Navitas Semiconductor Corporations recent SEC filings showingWeekly Risk Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Gains Report: Is Mangoceuticals Inc a momentum stockQuarterly Profit Review & Momentum Based Trading Ideas - baoquankhu1.vn
Advanced Biomed Inc Stock (ADVB) Financials Data
There is no financial data for Advanced Biomed Inc (ADVB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.04%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):